SpeeDx and the QuantuMDx Group are collaborating with the Foundation for Innovative New Diagnostics to assess the feasibility of developing low-cost, point-of-care tests for common sexually transmitted infections.
Read More
The Navify guidelines app pulls the latest clinical guidance for breast, colorectal, non-small cell lung, and prostate cancers from the National Comprehensive Cancer Network.
Read More
The company will use the funds to develop and market near-patient, 2- to 5-minute tests to detect and monitor biomarkers for inflammatory and autoimmune diseases and for metabolic syndromes.
Read More
To detect emergent sepsis, the study aims to develop a rapid diagnostic based on multiple biomarkers.
Read More
The POC test would immediately help prostate cancer patients who have undergone radical prostatectomy but have positive surgical margins.
Read More